| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net earnings | 567.2 | 336 | 182.6 | 665.1 |
| Depreciation and amortization | 809.8 | 526.2 | 254.4 | 732.7 |
| Share-based compensation | 66.1 | 40.8 | 19.6 | 79.9 |
| Income taxes | -174.7 | -132 | -15.6 | -181.2 |
| Receivables | 15.6 | 18.6 | 18.8 | 40.1 |
| Inventories | 86.2 | 40.2 | 3 | 38 |
| Accounts payable and accrued liabilities | -11.1 | 40.4 | -36.4 | -204.7 |
| Other assets and liabilities | -24.1 | -8.3 | 0.1 | 20.5 |
| Net cash provided by operating activities | 1,179.7 | 761 | 382.8 | 993.1 |
| Additions to instruments | 226.2 | 140.2 | 59.7 | 188.4 |
| Additions to other property, plant and equipment | 149.7 | 94.7 | 44.6 | 152.3 |
| Net investment hedge settlements | 5.3 | -3.5 | -1 | -19.3 |
| Business combination investments, net of acquired cash | 1,226.3 | 1,226.3 | - | 116.3 |
| Acquisition of intangible assets | 42.4 | 32.4 | 2.4 | 119.6 |
| Other investing activities | 3.8 | 0.3 | 0.3 | 39.7 |
| Net cash used in investing activities | -1,653.7 | -1,490.4 | -106 | -596.9 |
| Net payments on revolving facilities | - | - | - | 50 |
| Net proceeds from revolving facilities | - | 220 | 0 | - |
| Proceeds from senior notes | 2,492.1 | 1,748.1 | 1,748.1 | 700 |
| Redemption of senior notes | 863 | 863 | 863 | 0 |
| Payment on term loan | - | - | - | 0 |
| Dividends paid to stockholders | 142.8 | 95.3 | 47.8 | 148 |
| Proceeds from employee stock compensation plans | 38 | 17.1 | 16.7 | 81.6 |
| Business combination contingent consideration payments | 25 | 17.4 | 17.4 | 3.5 |
| Debt issuance costs | 22.7 | 17.3 | 16.1 | - |
| Deferred business combination payments | - | - | 0 | 8.8 |
| Repurchase of common stock | 237 | 237 | 229.8 | 795.8 |
| Other financing activities | -16.6 | -16.1 | -15.2 | -19.4 |
| Net cash provided by (used in) financing activities | 1,223 | 739.2 | 575.4 | -243.9 |
| Effect of exchange rates on cash and cash equivalents | 18.2 | 21.6 | 7 | 1 |
| Change in cash and cash equivalents | 767.2 | 31.4 | 859.1 | 153.3 |
| Cash and cash equivalents at beginning of period | 525.5 | 525.5 | 525.5 | 415.8 |
| Cash and cash equivalents at end of period | 1,292.7 | 556.9 | 1,384.5 | 569 |
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
ZIMMER BIOMET HOLDINGS, INC. (ZBH)